Oncolytics (ONCY) Biotech announced the appointment of Andrew Aromando as Chief Business Officer. Aromando most recently served as COO at Ambrx Biopharma.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.